Resultados de la búsqueda
Zuriaga MA, Fuster JJ. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis - Beyond Conventional Cardiovascular Risk Factors. CIRC J (2023) 87:394-400
Link to the full text in Repisalud
Link to the full text in Repisalud
Díez-Díez M, Amorós-Pérez M, de la Barrera J, Vázquez E, Quintas A, Pascual-Figal DA, Dopazo A, Sánchez-Cabo F, Kleinman ME, Gordon LB, Fuster V, Andrés V*, Fuster JJ* *co-corresponding authors Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. doi: 10.1007/s11357-022-00607-2. Geroscience (2023) 45:1231-1236
Link to the full text in Repisalud
Link to the full text in Repisalud
Zekavat SM, Viana-Huete V, Matesanz N, Jorshery SD, Zuriaga MA, Uddin MM, Trinder M, Paruchuri K, Zorita V, Ferrer-Pérez A, Amorós-Pérez M, Kunderfranco P, Carriero R, Greco CM, Aroca-Crevillen A, Hidalgo A, Damrauer SM, Ballantyne CM, Niroula A, Gibson CJ, Pirruccello J, Griffin G, Ebert BL, Libby P, Fuster V, Zhao H, Ghassemi M, Natarajan P, Bick AG, Fuster JJ, Klarin D. TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nature Cardiovascular Research (2023) 2:144-158
Link to the full text in Repisalud
Link to the full text in Repisalud
Díez-Díez M, Fuster JJ Troublemaking mutations: Clonal hematopoiesis for the prediction of prognosis in ST-segment elevation myocardial infarction. EBioMedicine (2022) 79
Matesanz N, Viana-Huete V, Zuriaga MA, Zorita V, Ferrer-Perez A, Amoros-Perez M, Carriero R, Kunderfranco P, Greco CM, Fuster JJ. TP53-MUTANT CLONAL HEMATOPOIESIS ACCELERATES EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355
Amoros-Perez M, Zorita V, Moro-Moro R, Matesanz N, Viana-Huete V, Ferrer-Perez A, Fuster JJ. NO EFFECT OF RADIATION-RELATED CLONAL HEMATOPOIESIS DRIVEN BY PPM1D MUTATIONS ON EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355:E125-E125
Yoshida Y, Shimizu I, Shimada A, Nakahara K, Yanagisawa S, Kubo M, Fukuda S, Ishii C, Yamamoto H, Ishikawa T, Kano K, Aoki J, Katsuumi G, Suda M, Ozaki K, Yoshida Y, Okuda S, Ohta S, Okamoto S, Minokoshi Y, Oda K, Sasaoka T, Abe M, Sakimura K, Kubota Y, Yoshimura N, Kajimura S, Zuriaga M, Walsh K, Soga T, Minamino T. Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism. Sci Rep (2022) 12
Link to the full text in Repisalud
Link to the full text in Repisalud
Fuster JJ. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors. Thromb Res (2022) 213:S107-S112
Tall AR, Fuster JJ. Clonal hematopoiesis in cardiovascular disease and therapeutic implications. Nature Cardiovascular Research (2022) 1:116-124
Link to the full text in Repisalud
Link to the full text in Repisalud
Pascual-Figal DA, Bayes-Genis A, Díez-Díez M, Hernández-Vicente Á, Vázquez-Andrés D, de la Barrera J, Vazquez E, Quintas A, Zuriaga MA, Asensio-López MC, Dopazo A, Sánchez-Cabo F, Fuster JJ Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction J Am Coll Cardiol (2021) 77:1747-1759